Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease

Código QR

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease

Samuel FrankBoston University School of Medicine, Boston, Massachusetts, USAAbstract: Huntington disease (HD) is a dominantly inherited progressive neurological disease characterized by chorea, an involuntary brief movement that tends to flow between body regions. HD is typically diagnosed based on...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Samuel Frank
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/21be499c52914b2eaec60e9b04de8980
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
por: Andrea Ciammola, et al.
Publicado: (2008)

Tetrabenazine-induced oculogyric crisis – a rare complication in the treatment of Gilles de la Tourette syndrome
por: Janik P, et al.
Publicado: (2016)

Preventive treatment in migraine and the new US guidelines
por: Estemalik E, et al.
Publicado: (2013)

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
por: Ann E Maloney, et al.
Publicado: (2010)

Drug and alcohol misuse in first episode psychosis: An observational study
por: Kathleen Crebbin, et al.
Publicado: (2008)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
por: Harada E, et al.
Publicado: (2015)

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
por: Goto N, et al.
Publicado: (2012)

Novel glutamatergic drugs for the treatment of mood disorders
por: Murrough JW, et al.
Publicado: (2013)

Influence of drug treatment with antidepressants and antipsychotics on plasma urea levels
por: Lozano Ortiz R
Publicado: (2012)

First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment
por: Flórez G, et al.
Publicado: (2015)

Current trends in drug treatment of obsessive&ndash;compulsive disorder
por: Eric H Decloedt, et al.
Publicado: (2010)

Varenicline improves motor and cognitive symptoms in early Huntington’s disease
por: McGregor AL, et al.
Publicado: (2016)

Subchronic treatment with antiepileptic drugs modifies pentylenetetrazol-induced seizures in mice: Its correlation with benzodiazepine receptor binding
por: Luisa Rocha
Publicado: (2008)

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
por: Jara M, et al.
Publicado: (2013)

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing&ndash;remitting multiple sclerosis?
por: Mezei Z, et al.
Publicado: (2012)

No change in N-acetyl aspartate in first episode of moderate depression after antidepressant treatment: 1H magnetic spectroscopy study of left amygdala and left dorsolateral prefrontal cortex
por: Bajs Janović M, et al.
Publicado: (2014)

Role of endocannabinoids in regulating drug dependence
por: Daniela Parolaro, et al.
Publicado: (2007)

Assessing suicidal risk with antiepileptic drugs
por: Marco Mula, et al.
Publicado: (2010)

The influence of atypical antipsychotic drugs on sexual function
por: Just MJ
Publicado: (2015)

New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Nurcan &Uuml;&ccedil;eyler, et al.
Publicado: (2008)

Role of nucleus accumbens glutamatergic plasticity in drug addiction
por: Quintero GC
Publicado: (2013)

Nomenclature of drug-induced pityriasis rosea-like rashes
por: Chuh AAT
Publicado: (2015)

First true initial ictal SPECT in partial epilepsy verified by electroencephalography
por: Jes&uacute;s Pastor, et al.
Publicado: (2008)

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
por: Masopust J, et al.
Publicado: (2015)

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
por: Hayashi K, et al.
Publicado: (2014)

Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression
por: Sozeri-Varma G, et al.
Publicado: (2013)

Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo
por: Yanik ME, et al.
Publicado: (2014)

Quality of life and personality traits in patients with malignant pleural mesothelioma and their first-degree caregivers
por: Granieri A, et al.
Publicado: (2013)

Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry
por: Willem MA Verhoeven, et al.
Publicado: (2010)

Cluster headache as a first manifestation of multiple sclerosis: case report and literature review
por: Mijajlović MD, et al.
Publicado: (2014)

A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice
por: Bod&eacute;n R, et al.
Publicado: (2013)

Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy
por: Ghaydaa A Shehata, et al.
Publicado: (2009)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
por: Adam UU, et al.
Publicado: (2014)

Levetiracetam in the treatment of epilepsy
por: Bassel Abou-Khalil
Publicado: (2008)

Almotriptan in the treatment of migraine
por: Giorgio Sandrini, et al.
Publicado: (2007)

Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
por: Chien WT, et al.
Publicado: (2013)

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia
por: Hirano J, et al.
Publicado: (2013)

An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis
por: Si TM, et al.
Publicado: (2015)

Varenicline in the treatment of tobacco dependence
por: Karl Fagerstr&ouml;m, et al.
Publicado: (2008)

Pharmacotherapy for treatment-resistant schizophrenia
por: Meghan E Mcilwain, et al.
Publicado: (2011)